Research Progress on Signal Conversion Based on Aptamer Combined CRISPR/Cas System in Biosensors

Molecular Diagnosis and Therapy · Published 2025-06-18 · DOI 10.1007/s40291-025-00785-7

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40291-025-00785-7

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

Evolution of CRISPR-Cas Detection Systems: From Nucleic Acid Recognition to Omnidirectional Point-of-Care Diagnostic Applications · Diagnostic Microbiology and Infectious Disease · 2026 · Cites or is cited by this article
Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis · Molecular Diagnosis and Therapy · 2025 · Same journal
Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine · Molecular Diagnosis and Therapy · 2025 · Same journal
Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies · Molecular Diagnosis and Therapy · 2025 · Same journal
Tividenofusp Alfa: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal
Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics · Molecular Diagnosis and Therapy · 2026 · Same journal
The Future of Chemogenetics for the Treatment of Spasticity · Molecular Diagnosis and Therapy · 2025 · Same journal
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors · Molecular Diagnosis and Therapy · 2026 · Same journal
Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy · Molecular Diagnosis and Therapy · 2026 · Same journal
Marnetegragene Autotemcel: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal